Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

PGRN-RIKEN:Genome-Wide Association Study of Drug-Induced Long-QT Syndrome

ABSTRACT: PGRN-RIKEN:Genome-Wide Association Study of Drug-Induced Long-QT Syndrome

PROVIDER: PRJNA75677 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

PGRN-RIKEN Mayo Breast Cancer

Project description:PGRN-RIKEN Mayo Breast Cancer

| PRJNA75545 | ENA

PGRN-RIKEN Mayo-NSABP Prevention Study

Project description:PGRN-RIKEN Mayo-NSABP Prevention Study

| PRJNA75693 | ENA

PGRN-RIKEN: Genome-Wide Association Study of Drug-Induced Long-QT Syndrome

Project description:<p>The goal of this study was to identify genetic risk factors for drug-induced prolongation of the QT interval (diLQT) and the ventricular arrhythmia torsades de pointes (TdP). We conducted a genome-wide association study (GWAS) focusing on subjects with a history of long QT and/or TdP after taking medication. Controls for this study were individuals with a history of cardiac arrhythmias who had begun treatment with potentially QT-prolonging antiarrhythmics. An additional control group of normal volunteers were given ibutilide, a drug with documented proarrhythmic properties. All study participants were recruited and treated/evaluated at Vanderbilt University Medical Center.</p> <p>This study was conducted by the Pharmacogenomics of Arrhythmia Therapy subgroup of the Pharmacogenetics Research Network, a nationwide collaboration of scientists studying the genetic contributions to drug response variability. Genotyping was performed by the RIKEN research institute in Japan using the Illumina 610 Quad Beadchip platform.</p>

| phs000331 | dbGaP

Homo sapiens

Project description:PGRN-RIKEN:Genome-Wide Association Study of Drug-Induced Long-QT Syndrome

| PRJNA75679 | ENA

PGRN-RIKEN: Rate Control Therapy in Patients with Atrial Fibrillation

Project description:PGRN-RIKEN: Rate Control Therapy in Patients with Atrial Fibrillation

| PRJNA80275 | ENA

PGRN – RIKEN: Genetic Determinants of Clinical Cardiovascular Events in Patients Receiving Statins

Project description:PGRN – RIKEN: Genetic Determinants of Clinical Cardiovascular Events in Patients Receiving Statins

| PRJNA290826 | ENA

A Genome-Wide Association Study in Patients Experiencing Drug-Induced Long-QT Syndrome and/or Torsades de Pointes; A Collaboration Between the NIH Pharmacogenomics Research Network and the RIKEN Yokohama Institute Center for Genomic Medicine

| phs000331.v1.p1 | EGA

PGRN-RIKEN-CALGB 80303 - Genome-wide Pharmacogenomic Study of Gemcitabine and Bevacizumab in Advanced Pancreatic Cancer

Project description:PGRN-RIKEN-CALGB 80303 - Genome-wide Pharmacogenomic Study of Gemcitabine and Bevacizumab in Advanced Pancreatic Cancer

| PRJNA75653 | ENA

PGRN-RIKEN-CALGB 40101 - Genome-wide Pharmacogenomic Study of Cyclophosphamide, Doxorubicin and Paclitaxel in Breast Cancer

Project description:PGRN-RIKEN-CALGB 40101 - Genome-wide Pharmacogenomic Study of Cyclophosphamide, Doxorubicin and Paclitaxel in Breast Cancer

| PRJNA262702 | ENA

Systematic expression profiling of the mouse transcriptome using RIKEN cDNA microarrays

Project description:Expression profiling of multiple mouse tissues against 57931 RIKEN cDNAs Keywords: dual color nucleotide, tissue comparison

2005-12-20 | GSE3098 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data